Latterell Venture Partners
Overview
Latterel Venture Partners is a Biotechnology company located in 4 Embarcadero Ctr, San Francisco, California, United States.
Investment Focus
- Innovative technologies
- Large market opportunities
- Passionate entrepreneurs
Portfolio Companies
Reach Latterell Venture Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Latterell Venture Partners
What sectors does Latterell Venture Partners invest in?
Latterell Venture Partners invests in Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Healthcare IT, and is based in San Francisco, California, United States. Latterell Venture Partners is listed as a venture capital in the ConnectSafely investor database.
What stage does Latterell Venture Partners invest at?
Latterell Venture Partners backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 50K - 10M.
Which regions does Latterell Venture Partners invest in?
Latterell Venture Partners invests across United States.
Who are the partners at Latterell Venture Partners?
Team members listed for Latterell Venture Partners include Steve Salmon (General Partner) and Ken Widder (general partner).
What companies has Latterell Venture Partners invested in?
Latterell Venture Partners's portfolio includes Viracta Therapeutics, Cellective Therapeutics, HemaQuest Pharmaceuticals, Naurex and Transcend Medical.
How do I contact Latterell Venture Partners?
Latterell Venture Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
